JW Pharmaceutical Corporation (001067.KS) KSC

61,000.00

-200(-0.33%)

Updated at November 07 03:30PM

Currency In KRW

Valuation

Market Cap559.8B
Enterprise Value641.1B
P/E Ratio10.87
PEG Ratio-0.65
Price/Sales Ratio0.75
Price/Book Ratio1.74
Enterprise/Revenue0.86
Enterprise/EBITDA3.48

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.07
Operating Margin0.12

Management Effectiveness

Return On Assets0.09
Return On Equity0.16

Income Statement

Revenue719.38B
Revenue/Share32,012.37
Gross Profit323.5B
EBITDA110.17B
Net Income65.04B
Diluted EPS2,644.47

Balance Sheet

Total Cash72.53B
Total Cash/Share1,508.94
Total Debt90.73B
Total Debt/Equity0.28
Current Ratio1.41
Book Value Per Share13,931.31

Price History

52-Week Change-1.45
52-Week High65,600
52-Week Low56,100
Moving Average 50 Days59,694
Moving Average 200 Days61,253.5

Statistics

Average Volume54
Shares Outstanding8.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate450
Trailing Annual Dividend Yield1.85
Payout Ratio0.21
Last Split Factor51:50
Last Split DateDecember 27, 2023